Menu
close
Menu
close
Menu
close

UK SPINE Recording

Our CEO, David Weinkove, discusses the use of C. elegans and how they could be used in the field of Geroscience to accelerate the drug development process.

Related Resources

2024 Trends & Predictions: Gut Health, Mood, and Market Innovation
2024 Trends & Predictions: Gut Health, Mood, and Market Innovation...Read More
Personal Care Magazine: Developing Efficient Probiotics in Ageing
Personal Care Magazine: Developing Efficient Probiotics in Ageing...Read More
Technology Networks: Addressing Key Limitations in Disease Models
Technology Networks Feature: Addressing Key Limitations in Disease Models...Read More
Brochure: Pharma & Biotech
Brochure: Pharma & Biotech - read and download the brochure...Read More
IBI Feature: Accelerating Drug Discovery for Diseases of Ageing: In Vivo High Throughput Screening With C. elegans
IBI Feature: Accelerating Drug Discovery for Diseases of Ageing: In Vivo High Throughput Screening W...Read More
Magnitude Biosciences Podcast Ep 1 | Dr Alex Parker: Screening probiotics to treat ALS with C. elegans
Magnitude Biosciences Podcast Ep 1 | Dr Alex Parker: Screening probiotics to treat ALS with worms...Read More
The Nematode Corner: Delaying Forgetting – How Ice and Lithium Affect Memory in C. elegans
Delaying Forgetting - How Ice and Lithium Affect Memory in C. elegans...Read More
The Nematode Corner: Toxicity Testing with C. elegans
Welcome back to “The Nematode Corner” where we explore the fascinating world of Caenorha...Read More
Brochure: Health & Nutrition
Brochure: Health & Nutrition - read and download the brochure...Read More
Probiota 2024: Exploring Probiotic Efficacy Beyond CFUs
A couple of weeks ago we attended Probiota 2024 in Milan, a global meeting to discuss the science an...Read More
Case Study: Identifying a lead candidate for slowing ageing with Gerostate Alpha
GeroState Alpha is a pharmaceutical company, based at the Buck Institute for Research on Ageing in N...Read More
Case Study: Measuring efficacy to slow ageing for drug discovery biotech Five Alarm Bio
Five Alarm Bio, a UK drug discovery startup focussing on the underlying mechanisms of ageing to deve...Read More
The Nematode Corner: Unearthing Nutraceutical Discoveries
Welcome back to “The Nematode Corner,” where we continue our journey into the extraordin...Read More
The Nematode Corner: Powering Industry Progress
Welcome to the fascinating world of C. elegans, a microscopic nematode worm that holds the key to un...Read More
Case Study – AB Biotek works with Magnitude Biosciences to accelerate probiotic development
We help our partners in the nutraceuticals & ingredients industry uncover and validate the diver...Read More
Pharmaceutical company Lundbeck in collaboration with Magnitude Biosciences on innovative new platform to test interventions for neurodegenerative disease
Lundbeck collaborates with Magnitude on innovate platform to test neurodegenerative disease interven...Read More
Tiny Worms- Experiments Fast
David Weinkove, CEO of Magnitude Biosciences joins New Matter ...Read More
Case Study: Michelin & Magnitude Biosciences
Michelin, a Fortune 500 consumer good manufacturing company and the global leader in tyre manufactur...Read More
ELRIG Drug Discovery 2021
Take a look at our Poster from ELRIG Drug Discovery 2021: Automated Monitoring of C. elegans&nb...Read More
Frontiers in Aging: Applying C. elegans to industrial drug discovery
Just published in Frontiers in Aging: Applying C. elegans to industrial drug discovery...Read More
C. elegans to accelerate industrial drug discovery and address the costs and challenges of early preclinical research
Magnitude Bioscience CEO, David Weinkove, discusses the application of C. elegans to accelerate the ...Read More
Developing a System to Quantify Efficacy of Neurodegeneration Therapeutics Using Automated Monitoring of C. elegans
Check out our poster showing how we can quantify the efficacy of neurodegeneration models...Read More
C. elegans mobility decline
This video shows an automated method to quantify that decline developed by Magnitude Biosciences whi...Read More
Neuronal SKN-1B modulates nutritional signalling pathways and mitochondrial networks to control satiety
Neuronal SKN-1B modulates nutritional signalling pathways and mitochondrial networks to control sati...Read More
Chemosensory Neurons Modulate the Response to Oomycete Recognition in Caenorhabditis elegans
The Barkoulas Lab, including our own Michael Fasseas , find an Oomycetes recognition response in&nbs...Read More
UK SPINE Recording
Our CEO, David Weinkove, discusses the use of C. elegans and how they could be used in the...Read More
Microbiome SIG Webinar Series
Our CEO, Dr. David Weinkove, explains how healthspan readouts can be used to understand mechanisms i...Read More
Automated Imaging of C. elegans for Ageing, Neurodegeneration and Behaviour
How large scale non-invasive imaging of C. elegans to enable reliable measurement of Agein...Read More
C. elegans Automated Imaging Platform
Magnitude Biosciences presentation from ELRIG online 2020 on the use of C. elegans in pre-...Read More
C. elegans Automated Imaging in Drug Discovery
De-risking drug candidates ahead of rodent studies with a non-mammalian model for ageing, neurodegen...Read More
An overview of the use of C. elegans in longevity research including the genetic manipulation of animals.
An overview of the use of C. elegans in longevity research including the genetic manipulat...Read More

Get regular updates in your inbox

Sign up to our newsletter today, to get access to the latest company and industry news

Our Services
Ageing & Longevity
Microbiome
Neurodegeneration
Toxicity
Transgenics

Who we help
Health & Nutrition
Biotechnology
Pharma
Academia

Why C. elegans ?
WormGazerTM Technology

Company
About Us
Our Team
Testimonials
Jobs

News
Resources
Contact

Legal

Privacy
Cookies